137 related articles for article (PubMed ID: 34822459)
1. Discovery of GOT1 Inhibitors from a Marine-Derived
Yan S; Qi C; Song W; Xu Q; Gu L; Sun W; Zhang Y
Mar Drugs; 2021 Oct; 19(11):. PubMed ID: 34822459
[TBL] [Abstract][Full Text] [Related]
2. A covalent small molecule inhibitor of glutamate-oxaloacetate transaminase 1 impairs pancreatic cancer growth.
Yoshida T; Yamasaki S; Kaneko O; Taoka N; Tomimoto Y; Namatame I; Yahata T; Kuromitsu S; Cantley LC; Lyssiotis CA
Biochem Biophys Res Commun; 2020 Feb; 522(3):633-638. PubMed ID: 31787239
[TBL] [Abstract][Full Text] [Related]
3. Aspulvinone O, a natural inhibitor of GOT1 suppresses pancreatic ductal adenocarcinoma cells growth by interfering glutamine metabolism.
Sun W; Luan S; Qi C; Tong Q; Yan S; Li H; Zhang Y
Cell Commun Signal; 2019 Aug; 17(1):111. PubMed ID: 31470862
[TBL] [Abstract][Full Text] [Related]
4. Biochemical Characterization and Structure-Based Mutational Analysis Provide Insight into the Binding and Mechanism of Action of Novel Aspartate Aminotransferase Inhibitors.
Holt MC; Assar Z; Beheshti Zavareh R; Lin L; Anglin J; Mashadova O; Haldar D; Mullarky E; Kremer DM; Cantley LC; Kimmelman AC; Stein AJ; Lairson LL; Lyssiotis CA
Biochemistry; 2018 Nov; 57(47):6604-6614. PubMed ID: 30365304
[TBL] [Abstract][Full Text] [Related]
5. Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming.
Yang Y; Zheng M; Han F; Shang L; Li M; Gu X; Li H; Chen L
J Mol Med (Berl); 2022 Apr; 100(4):599-612. PubMed ID: 35212782
[TBL] [Abstract][Full Text] [Related]
6. Discovery and optimization of aspartate aminotransferase 1 inhibitors to target redox balance in pancreatic ductal adenocarcinoma.
Anglin J; Zavareh RB; Sander PN; Haldar D; Mullarky E; Cantley LC; Kimmelman AC; Lyssiotis CA; Lairson LL
Bioorg Med Chem Lett; 2018 Sep; 28(16):2675-2678. PubMed ID: 29731362
[TBL] [Abstract][Full Text] [Related]
7. Butenolides from a marine-derived fungus Aspergillus terreus with antitumor activities against pancreatic ductal adenocarcinoma cells.
Qi C; Gao W; Guan D; Wang J; Liu M; Chen C; Zhu H; Zhou Y; Lai Y; Hu Z; Zhou Q; Zhang Y
Bioorg Med Chem; 2018 Dec; 26(22):5903-5910. PubMed ID: 30392953
[TBL] [Abstract][Full Text] [Related]
8. GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells.
Abrego J; Gunda V; Vernucci E; Shukla SK; King RJ; Dasgupta A; Goode G; Murthy D; Yu F; Singh PK
Cancer Lett; 2017 Aug; 400():37-46. PubMed ID: 28455244
[TBL] [Abstract][Full Text] [Related]
9. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma.
Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R
J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of GOT1 sensitizes colorectal cancer cells to 5-fluorouracil.
Hong C; Zheng J; Li X
Cancer Chemother Pharmacol; 2017 Apr; 79(4):835-840. PubMed ID: 28314989
[TBL] [Abstract][Full Text] [Related]
11. The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolism.
Zhu H; Xiao Y; Guo H; Guo Y; Huang Y; Shan Y; Bai Y; Lin X; Lu H
Aging (Albany NY); 2021 Dec; 13(23):25089-25105. PubMed ID: 34863080
[TBL] [Abstract][Full Text] [Related]
12. GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis.
Kremer DM; Nelson BS; Lin L; Yarosz EL; Halbrook CJ; Kerk SA; Sajjakulnukit P; Myers A; Thurston G; Hou SW; Carpenter ES; Andren AC; Nwosu ZC; Cusmano N; Wisner S; Mbah NE; Shan M; Das NK; Magnuson B; Little AC; Savani MR; Ramos J; Gao T; Sastra SA; Palermo CF; Badgley MA; Zhang L; Asara JM; McBrayer SK; di Magliano MP; Crawford HC; Shah YM; Olive KP; Lyssiotis CA
Nat Commun; 2021 Aug; 12(1):4860. PubMed ID: 34381026
[TBL] [Abstract][Full Text] [Related]
13. miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1.
Wang J; Wang B; Ren H; Chen W
Biochem Biophys Res Commun; 2019 Jan; 509(1):241-248. PubMed ID: 30591220
[TBL] [Abstract][Full Text] [Related]
14. Adapalene inhibits ovarian cancer ES-2 cells growth by targeting glutamic-oxaloacetic transaminase 1.
Wang Q; Zhang Q; Luan S; Yang K; Zheng M; Li K; Chen L; Li H
Bioorg Chem; 2019 Dec; 93():103315. PubMed ID: 31605927
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Potent Small-Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity.
Chen X; Sun W; Huang S; Zhang H; Lin G; Li H; Qiao J; Li L; Yang S
J Med Chem; 2020 Sep; 63(18):10474-10495. PubMed ID: 32787077
[TBL] [Abstract][Full Text] [Related]
16. Targeting pancreatic cancer metabolic dependencies through glutamine antagonism.
Encarnación-Rosado J; Sohn ASW; Biancur DE; Lin EY; Osorio-Vasquez V; Rodrick T; González-Baerga D; Zhao E; Yokoyama Y; Simeone DM; Jones DR; Parker SJ; Wild R; Kimmelman AC
Nat Cancer; 2024 Jan; 5(1):85-99. PubMed ID: 37814010
[TBL] [Abstract][Full Text] [Related]
17. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
[TBL] [Abstract][Full Text] [Related]
18. Glutamic oxaloacetic transaminase 1 as a potential target in human cancer.
Song Z; Yang Y; Wu Y; Zheng M; Sun D; Li H; Chen L
Eur J Pharmacol; 2022 Feb; 917():174754. PubMed ID: 35007521
[TBL] [Abstract][Full Text] [Related]
19. The discovery of a non-competitive GOT1 inhibitor, hydralazine hydrochloride, via a coupling reaction-based high-throughput screening assay.
Wu Q; Sun Z; Chen Z; Liu J; Ding H; Luo C; Wang M; Du D
Bioorg Med Chem Lett; 2022 Oct; 73():128883. PubMed ID: 35820623
[TBL] [Abstract][Full Text] [Related]
20. Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex.
Wei H; Wang F; Wang Y; Li T; Xiu P; Zhong J; Sun X; Li J
Cancer Sci; 2017 Mar; 108(3):478-487. PubMed ID: 28002618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
